Common genetic variants and modifiable risk factors underpin hypertrophic cardiomyopathy susceptibility and expressivityCommon genetic variants and modifiable risk factors

Turk Kardiyol Dern Ars 2017;45(5):450-453 doi: 10.5543/tkda.2016.56267 Familial hypertrophic cardiomyopathy: A case with a new mutation in the MYBPC3 gene Ailevi hipertrofik

MEDICAL POLICY - GENETIC TESTING FOR INHERITED HYPERTROPHIC CARDIOMYOPATHYMedical Policy Joint Medical Policies are a source for BCBSM and BCN medical policy information

RBM20 Is a Candidate Gene for Hypertrophic CardiomyopathyRBM20 Is a Candidate Gene for Hypertrophic Cardiomyopathy Jiaqi Dai, MD,a,b Zongzhe Li, MD, PhD,a,b Wei Huang, MD,b

Hypertrophic Cardiomyopathy (HCM)Evaluation and DISCLOSURES (Asymmetric >> Symmetric) cardiovascular or systemic Gersh, BJ, et al. JACC 2011; 58: e212 ACC/AHA Guidelines

Genetic Testing for Hypertrophic CardiomyopathyGenetic testing for Hypertrophic Cardiomyopathy Image used with permission from Dr. Rick Nishimura, Mayo Clinic, Rochester,

v1.0.2022 Introduction Procedures addressed The inclusion of any procedure code in this table does not imply that the code is under management or requires prior authorization.

Shared Genetic Causes of Cardiac Hypertrophy in Children and Adults Hiroyuki Morita, M.D., Heidi L. Rehm, Ph.D., Andres Menesses, M.D., Barbara McDonough, R.N., Amy E. Roberts,

Srijita Sen-Chowdhry, MA, MBBS, MRCP, MD, FESC [1, 2] Daniel Jacoby, MD, FACC [3] James C. Moon, MBBCh, MD [1, 4] William J. McKenna, BA, MD, DSc, FRCP, FMedSci, FESC, FACC